Literature DB >> 9135153

Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.

E Gottlieb1, R Haffner, A King, G Asher, P Gruss, P Lonai, M Oren.   

Abstract

The p53 tumor suppressor protein is a sequence-specific transcriptional activator of target genes. Exposure of cells to DNA damage results in accumulation of biochemically active p53, with consequent activation of p53-responsive promoters. In order to study how the transcriptional activity of the p53 protein is regulated in vivo, a transgenic mouse strain was generated. These mice harbor the p53-dependent promoter of the mdm2 gene, fused to a lacZ reporter gene. Induction of lacZ activity by DNA damage (ionizing radiation) was monitored in embryos of different p53 genotypes. The transgenic promoter was substantially activated in vivo following irradiation; activation required functional p53. The activation pattern became more restricted with increasing embryo age, as well as with the state of differentiation of a given tissue. Generally, maximal p53 activation occurred in rapidly proliferating, relatively less differentiated cells. A striking extent of haploinsufficiency was revealed-induction of promoter activity was far less efficient in mice carrying only one wild-type p53 allele. This suggests that normal levels of cellular p53 are limiting, and any further reduction already compromises the p53 response significantly. Thus, the activation potential of p53 is tightly controlled in vivo, both spatially and temporally, and an important element in this control is the presence of limiting basal levels of activatable p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135153      PMCID: PMC1169735          DOI: 10.1093/emboj/16.6.1381

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

Review 1.  Biochemical properties and biological effects of p53.

Authors:  R Haffner; M Oren
Journal:  Curr Opin Genet Dev       Date:  1995-02       Impact factor: 5.578

2.  Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

Authors:  T Juven; Y Barak; A Zauberman; D L George; M Oren
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

3.  Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.

Authors:  M Oren; N C Reich; A J Levine
Journal:  Mol Cell Biol       Date:  1982-04       Impact factor: 4.272

4.  Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.

Authors:  N C Reich; M Oren; A J Levine
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

5.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

6.  Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.

Authors:  M Oren; W Maltzman; A J Levine
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

7.  The amino acid sequence of murine p53 determined from a c-DNA clone.

Authors:  D Pennica; D V Goeddel; J S Hayflick; N C Reich; C W Anderson; A J Levine
Journal:  Virology       Date:  1984-04-30       Impact factor: 3.616

8.  Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?

Authors:  X Lu; D P Lane
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.

Authors:  A Zauberman; A Lupo; M Oren
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.

Authors:  A Rogel; M Popliker; C G Webb; M Oren
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

View more
  59 in total

1.  Using targeted transgenic reporter mice to study promoter-specific p53 transcriptional activity.

Authors:  Amanda M Goh; Chin Yan Lim; Poh Cheang Chiam; Ling Li; Michael B Mann; Karen M Mann; Sergio Menendez; David P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  p53 in stem cells.

Authors:  Valeriya Solozobova; Christine Blattner
Journal:  World J Biol Chem       Date:  2011-09-26

Review 3.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

4.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

5.  Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours.

Authors:  B K Nayak; B R Das
Journal:  Mol Biol Rep       Date:  1999-12       Impact factor: 2.316

6.  Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.

Authors:  Satoshi Yamasaki; Naoko Yagishita; Takeshi Sasaki; Minako Nakazawa; Yukihiro Kato; Tadayuki Yamadera; Eunkyung Bae; Sayumi Toriyama; Rie Ikeda; Lei Zhang; Kazuko Fujitani; Eunkyung Yoo; Kaneyuki Tsuchimochi; Tomohiko Ohta; Natsumi Araya; Hidetoshi Fujita; Satoko Aratani; Katsumi Eguchi; Setsuro Komiya; Ikuro Maruyama; Nobuyo Higashi; Mitsuru Sato; Haruki Senoo; Takahiro Ochi; Shigeyuki Yokoyama; Tetsuya Amano; Jaeseob Kim; Steffen Gay; Akiyoshi Fukamizu; Kusuki Nishioka; Keiji Tanaka; Toshihiro Nakajima
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

7.  Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint.

Authors:  Gustavo Pedraza-Alva; Miroslav Koulnis; Colette Charland; Tina Thornton; James L Clements; Mark S Schlissel; Mercedes Rincón
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

8.  The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration.

Authors:  Simone Di Giovanni; Chad D Knights; Mahadev Rao; Alexander Yakovlev; Jeannette Beers; Jason Catania; Maria Laura Avantaggiati; Alan I Faden
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

9.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

10.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

Authors:  M L Fero; E Randel; K E Gurley; J M Roberts; C J Kemp
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.